Literature DB >> 10385665

Hepatitis cRNA quasispecies complexity in patients with alcoholic liver disease.

K E Sherman1, S D Rouster, C Mendenhall, D Thee.   

Abstract

Alcohol abuse is described as a major cofactor in the development of hepatitis C (HCV) associated liver disease and may play a role in the outcome of interferon-based treatment interventions. The association between HCV viral heterogeneity and alcohol has not been previously described. This study was designed to evaluate the quasispecies nature of the HCV population in patients with compensated and decompensated alcoholic liver disease, to test the hypothesis that alcoholics have greater complexity than matched nonalcoholic controls. A nonisotopic heteroduplex complexity assay (HCA) was first validated by comparison with results of quasispecies complexity determined by subcloning and sequencing of amplicon products from the E2/NS1 hypervariable coding region (HVR). Subsequently, this methodology was applied to comparison of 20 compensated (Child's-Pugh A) and decompensated (Child's-Pugh B/C) alcoholic and 20 nonalcoholic controls. The complexity of the HVR, as well as the 5' Untranslated (5'UT) and the NS5b coding domains were evaluated. The HCA methodology provided a reasonable semiquantitative measure of HCV RNA quasispecies variability compared with subclone sequence homology comparison. Overall, alcoholic patients had greater quasispecies complexity (2.65 bands) than nonalcoholic controls (1.6 bands; P =.01). Subset analysis revealed that compensated alcoholic patients had a mean of 3.1 homo/heteroduplex bands per sample whereas Child's-Pugh B/C alcoholics showed intermediate complexity. A similar quasispecies complexity difference was seen in the 5'UTR, but not in the NS5b coding domain. Quasispecies complexity was not associated with viral titer, complementary DNA concentration, or genotype. The differences in quasispecies complexity may help explain reports of poor interferon responsiveness in alcoholic patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10385665     DOI: 10.1002/hep.510300131

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  6 in total

Review 1.  Alcohol use and hepatitis C.

Authors:  Marion G Peters; Norah A Terrault
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

Review 2.  Alcoholic liver disease and hepatitis C virus infection.

Authors:  Ignacio Novo-Veleiro; Lucía Alvela-Suárez; Antonio-Javier Chamorro; Rogelio González-Sarmiento; Francisco-Javier Laso; Miguel Marcos
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

3.  Hepatitis C virus (HCV) quasispecies complexity and selection in HCV/HIV-coinfected subjects treated with interferon-based regimens.

Authors:  Kenneth E Sherman; Susan D Rouster; Sandra Stanford; Jason T Blackard; Norah Shire; Margaret Koziel; Marion Peters; Raymond T Chung
Journal:  J Infect Dis       Date:  2010-03       Impact factor: 5.226

4.  Ethanol and reactive species increase basal sequence heterogeneity of hepatitis C virus and produce variants with reduced susceptibility to antivirals.

Authors:  Scott Seronello; Jessica Montanez; Kristen Presleigh; Miriam Barlow; Seung Bum Park; Jinah Choi
Journal:  PLoS One       Date:  2011-11-08       Impact factor: 3.240

Review 5.  Hepatitis C, innate immunity and alcohol: friends or foes?

Authors:  Natalia A Osna; Murali Ganesan; Kusum K Kharbanda
Journal:  Biomolecules       Date:  2015-02-05

6.  Diversity of the hepatitis C virus NS5B gene during HIV co-infection.

Authors:  Tshegofatso Ngwaga; Ling Kong; Derrick Lin; Cassandra Schoborg; Lynn E Taylor; Kenneth H Mayer; Robert S Klein; David D Celentano; Jack D Sobel; Denise J Jamieson; Caroline C King; John E Tavis; Jason T Blackard
Journal:  PLoS One       Date:  2020-08-04       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.